top of page
![Logo Aptol[57]_edited.png](https://static.wixstatic.com/media/08be47_8f40738dd0f84d4c8e1ba708d2f9382b~mv2.png/v1/crop/x_2,y_0,w_968,h_195/fill/w_259,h_52,al_c,q_85,usm_0.66_1.00_0.01,enc_auto/Logo%20Aptol%5B57%5D_edited.png)
News
August 2023
Anders Dyhr Dombernowsky-Toft joined the team of Aptol Pharma as the Chairman of the Board of Directors.
Lise Bastue, Msc in applied chemistry, DTU, joined the team as a research assistant. She will be working on preclinical development of APT001.
October 2023
Nicolai Wagtmann joined our Board of Directors.
bottom of page